Comprehensive Stock Comparison
Compare UiPath Inc. (PATH) vs MicroAlgo Inc. (MLGO) Stock
Analyze side-by-side fundamentals, valuation, growth, and profitability to decide which stock is the better buy.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Quick Verdict
| Category | Winner | Why |
|---|---|---|
| Growth | PATH | 9.3% revenue growth vs MLGO's -9.2% |
| Value | MLGO | Lower P/E (6.5x vs 16.0x) |
| Quality / Margins | PATH | 14.8% net margin vs MLGO's 11.1% |
| Stability / Safety | MLGO | Beta 0.16 vs PATH's 1.34 |
| Dividends | Tie | Neither pays a meaningful dividend |
| Momentum (1Y) | PATH | -12.8% vs MLGO's -97.1% |
| Efficiency (ROA) | PATH | 7.9% ROA vs MLGO's 2.1%, ROIC -11.8% vs 14.1% |
Who Each Stock Is For
Income & stability
Growth exposure
Long-term compounding (10Y)
Sleep-well-at-night portfolio
Defensive / Recession hedge
Business Model
What each company does and how it makes money
UiPath is a leading provider of robotic process automation (RPA) software that helps businesses automate repetitive digital tasks. The company generates revenue primarily through software licenses and cloud subscriptions — with its platform segment contributing roughly 80% of revenue — along with maintenance and support services. Its key competitive advantage lies in its comprehensive, AI-powered automation platform that combines process discovery, low-code development, and enterprise-grade management tools, creating significant switching costs for large enterprise customers.
MicroAlgo develops central processing algorithm solutions that optimize computing performance for clients in internet advertising, gaming, and intelligent chips. It generates revenue primarily through algorithm services — including optimization, data processing, and intelligence services — and secondarily through intelligent chip resale and software development. The company's competitive advantage lies in its proprietary algorithms that accelerate computing power without requiring hardware upgrades, offering cost-effective performance enhancements.
Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Financial Metrics Comparison
Side-by-side fundamentals across 2 stocks. BestLagging
Financial Scorecard
PATH leads in 3 of 6 categories — strongest in Financial Metrics and Profitability & Efficiency. 2 categories are tied.
Financial Metrics (TTM)
PATH is the larger business by revenue, generating $1.6B annually — 25.4x MLGO's $61M. Profitability is closely matched — net margins range from 14.8% (PATH) to 11.1% (MLGO). On growth, PATH holds the edge at +15.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | PATHUiPath Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| RevenueTrailing 12 months | $1.6B | $61M |
| EBITDAEarnings before interest/tax | $13M | $4M |
| Net IncomeAfter-tax profit | $230M | $7M |
| Free Cash FlowCash after capex | $312M | $9M |
| Gross MarginGross profit ÷ Revenue | +83.2% | +26.8% |
| Operating MarginEBIT ÷ Revenue | +0.6% | +5.8% |
| Net MarginNet income ÷ Revenue | +14.8% | +11.1% |
| FCF MarginFCF ÷ Revenue | +20.1% | +14.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.9% | -34.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +19.5% | -8.2% |
Valuation Metrics
| Metric | PATHUiPath Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| Market CapShares × price | $797M | $36M |
| Enterprise ValueMkt cap + debt − cash | -$5M | -$85M |
| Trailing P/EPrice ÷ TTM EPS | -82.54x | 6.49x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.98x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | — | -30.45x |
| Price / SalesMarket cap ÷ Revenue | 0.56x | 0.48x |
| Price / BookPrice ÷ Book value/share | 3.26x | 0.23x |
| Price / FCFMarket cap ÷ FCF | 2.61x | 8.77x |
Profitability & Efficiency
PATH delivers a 11.9% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $2 for MLGO. PATH carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to MLGO's 0.16x. On the Piotroski fundamental quality scale (0–9), PATH scores 5/9 vs MLGO's 4/9, reflecting solid financial health.
| Metric | PATHUiPath Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +11.9% | +2.1% |
| ROA (TTM)Return on assets | +7.9% | +2.1% |
| ROICReturn on invested capital | -11.8% | +14.1% |
| ROCEReturn on capital employed | -7.5% | +2.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 4 |
| Debt / EquityFinancial leverage | 0.04x | 0.16x |
| Net DebtTotal debt minus cash | -$801M | -$121M |
| Cash & Equiv.Liquid assets | $880M | $144M |
| Total DebtShort + long-term debt | $78M | $23M |
| Interest CoverageEBIT ÷ Interest expense | — | 25.26x |
Total Returns (with DRIP)
A $10,000 investment in PATH five years ago would be worth $1,555 today (with dividends reinvested), compared to $1 for MLGO. Over the past 12 months, PATH leads with a -12.8% total return vs MLGO's -97.1%. The 3-year compound annual growth rate (CAGR) favors PATH at -10.2% vs MLGO's -93.3% — a key indicator of consistent wealth creation.
| Metric | PATHUiPath Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| YTD ReturnYear-to-date | -32.4% | -30.3% |
| 1-Year ReturnPast 12 months | -12.8% | -97.1% |
| 3-Year ReturnCumulative with dividends | -27.7% | -100.0% |
| 5-Year ReturnCumulative with dividends | -84.4% | -100.0% |
| 10-Year ReturnCumulative with dividends | -84.4% | -100.0% |
| CAGR (3Y)Annualised 3-year return | -10.2% | -93.3% |
Risk & Volatility
MLGO is the less volatile stock with a 0.16 beta — it tends to amplify market swings less than PATH's 1.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. PATH currently trades 54.1% from its 52-week high vs MLGO's 0.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | PATHUiPath Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.34x | 0.16x |
| 52-Week HighHighest price in past year | $19.84 | $972.00 |
| 52-Week LowLowest price in past year | $9.38 | $3.35 |
| % of 52W HighCurrent price vs 52-week peak | +54.1% | +0.4% |
| RSI (14)Momentum oscillator 0–100 | 36.0 | 41.8 |
| Avg Volume (50D)Average daily shares traded | 24.5M | 149K |
Analyst Outlook
| Metric | PATHUiPath Inc. | MLGOMicroAlgo Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | — |
| Price TargetConsensus 12-month target | $16.30 | — |
| # AnalystsCovering analysts | 24 | — |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | — |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +49.0% | 0.0% |
Historical Charts
Charts are rendered on first load. Hover for details.
Chart 1Total Return — 5 Years (Rebased to 100)
| Stock | Apr 21 | Feb 26 | Change |
|---|---|---|---|
| UiPath Inc. (PATH) | 100 | 18.17 | -81.8% |
| MicroAlgo Inc. (MLGO) | 100 | 0.01 | -100.0% |
UiPath Inc. (PATH) returned -84% over 5 years vs MicroAlgo Inc. (MLGO)'s -100%.
Chart 2Revenue Growth — 10 Years
| Stock | 2019 | 2025 | Change |
|---|---|---|---|
| UiPath Inc. (PATH) | $336M | $1.4B | +325.3% |
| MicroAlgo Inc. (MLGO) | $16M | $74M | +364.6% |
Chart 3Net Margin Trend — 10 Years
| Stock | 2019 | 2025 | Change |
|---|---|---|---|
| UiPath Inc. (PATH) | -154.7% | -5.2% | +96.7% |
| MicroAlgo Inc. (MLGO) | 39.0% | 7.1% | -81.7% |
Chart 4EPS Growth — 10 Years
| Stock | 2019 | 2025 | Change |
|---|---|---|---|
| UiPath Inc. (PATH) | -1 | -0.13 | +87.0% |
| MicroAlgo Inc. (MLGO) | 29.45 | 0.55 | -98.1% |
Chart 5Free Cash Flow — 5 Years
UiPath Inc. generated $306M FCF in 2025 (+1076% vs 2021). MicroAlgo Inc. generated $4M FCF in 2024 (-74% vs 2021).
PATH vs MLGO: Frequently Asked Questions
7 questions · data-driven answers · updated daily
01Is PATH or MLGO a better buy right now?
MicroAlgo Inc. (MLGO) offers the better valuation at 6.5x trailing P/E, making it the more compelling value choice. Analysts rate UiPath Inc. (PATH) a "Hold" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — PATH or MLGO?
Over the past 5 years, UiPath Inc. (PATH) delivered a total return of -84.4%, compared to -100.0% for MicroAlgo Inc. (MLGO). A $10,000 investment in PATH five years ago would be worth approximately $2K today (assuming dividends reinvested). Over 10 years, the gap is even starker: PATH returned -84.4% versus MLGO's -100.0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — PATH or MLGO?
By beta (market sensitivity over 5 years), MicroAlgo Inc. (MLGO) is the lower-risk stock at 0.16β versus UiPath Inc.'s 1.34β — meaning PATH is approximately 752% more volatile than MLGO relative to the S&P 500. On balance sheet safety, UiPath Inc. (PATH) carries a lower debt/equity ratio of 4% versus 16% for MicroAlgo Inc. — giving it more financial flexibility in a downturn.
04Which has better profit margins — PATH or MLGO?
MicroAlgo Inc. (MLGO) is the more profitable company, earning 7.1% net margin versus -5.2% for UiPath Inc. — meaning it keeps 7.1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MLGO leads at 3.7% versus -11.4% for PATH. At the gross margin level — before operating expenses — PATH leads at 82.7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
05Which pays a better dividend — PATH or MLGO?
None of the stocks in this comparison currently pay a material dividend. All are effectively zero-yield and should be held for capital appreciation rather than income.
06Is PATH or MLGO better for a retirement portfolio?
For long-horizon retirement investors, MicroAlgo Inc. (MLGO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.16)). Both have compounded well over 10 years (MLGO: -100.0%, PATH: -84.4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
07What are the main differences between PATH and MLGO?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both. In terms of investment character: PATH is a small-cap quality compounder stock; MLGO is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that beat both.